International Biotechnology Trust as of March 31, 2018
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 63 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 7.2 | $18M | 206k | 89.21 | |
| Shire | 5.8 | $15M | 99k | 149.39 | |
| Array BioPharma | 5.4 | $14M | 852k | 16.31 | |
| Neurocrine Biosciences (NBIX) | 5.0 | $13M | 154k | 82.92 | |
| Biogen Idec (BIIB) | 4.9 | $13M | 46k | 273.79 | |
| Regeneron Pharmaceuticals (REGN) | 4.8 | $12M | 36k | 344.35 | |
| Sage Therapeutics (SAGE) | 4.4 | $11M | 71k | 160.95 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.3 | $11M | 68k | 162.98 | |
| Gilead Sciences (GILD) | 3.9 | $9.9M | 131k | 75.39 | |
| Adamas Pharmaceuticals | 3.5 | $8.8M | 370k | 23.87 | |
| Exelixis (EXEL) | 3.4 | $8.6M | 388k | 22.14 | |
| Alexion Pharmaceuticals | 3.1 | $8.1M | 72k | 111.46 | |
| D Stemline Therapeutics | 2.9 | $7.5M | 493k | 15.25 | |
| Halozyme Therapeutics (HALO) | 2.7 | $7.0M | 359k | 19.59 | |
| Ligand Pharmaceuticals In (LGND) | 2.7 | $6.9M | 42k | 165.14 | |
| Incyte Corporation (INCY) | 2.4 | $6.1M | 73k | 83.33 | |
| Ionis Pharmaceuticals (IONS) | 2.2 | $5.6M | 127k | 44.08 | |
| BioMarin Pharmaceutical (BMRN) | 2.1 | $5.3M | 65k | 81.05 | |
| Alnylam Pharmaceuticals (ALNY) | 1.7 | $4.4M | 37k | 119.10 | |
| Clovis Oncology | 1.6 | $4.0M | 76k | 52.79 | |
| G1 Therapeutics (GTHX) | 1.5 | $3.8M | 103k | 37.02 | |
| Bluebird Bio (BLUE) | 1.3 | $3.4M | 20k | 170.65 | |
| Kalvista Pharmaceuticals (KALV) | 1.2 | $3.0M | 322k | 9.33 | |
| Agios Pharmaceuticals (AGIO) | 1.2 | $3.0M | 37k | 81.78 | |
| Jazz Pharmaceuticals (JAZZ) | 1.1 | $2.9M | 19k | 150.89 | |
| Synergy Pharmaceuticals | 1.1 | $2.7M | 1.5M | 1.81 | |
| Puma Biotechnology (PBYI) | 0.9 | $2.3M | 34k | 68.00 | |
| Seattle Genetics | 0.9 | $2.2M | 43k | 52.31 | |
| Ultragenyx Pharmaceutical (RARE) | 0.8 | $2.1M | 41k | 50.98 | |
| Avexis | 0.8 | $2.1M | 17k | 123.53 | |
| Sarepta Therapeutics (SRPT) | 0.8 | $2.0M | 27k | 74.07 | |
| Molecular Templates | 0.8 | $2.0M | 248k | 7.99 | |
| Cymabay Therapeutics | 0.7 | $1.9M | 145k | 12.99 | |
| Axogen (AXGN) | 0.7 | $1.8M | 50k | 36.46 | |
| Penumbra (PEN) | 0.6 | $1.6M | 14k | 115.57 | |
| Beigene (BGNE) | 0.6 | $1.6M | 9.5k | 168.00 | |
| Deciphera Pharmaceuticals (DCPH) | 0.6 | $1.5M | 77k | 20.03 | |
| Transenterix | 0.6 | $1.5M | 889k | 1.69 | |
| Intersect Ent | 0.6 | $1.5M | 37k | 39.24 | |
| Fibrogen (FGEN) | 0.6 | $1.4M | 31k | 46.15 | |
| Globus Med Inc cl a (GMED) | 0.6 | $1.4M | 29k | 49.83 | |
| Merus N V (MRUS) | 0.5 | $1.4M | 75k | 18.53 | |
| Paratek Pharmaceuticals | 0.5 | $1.3M | 104k | 13.00 | |
| Rigel Pharmaceuticals (RIGL) | 0.5 | $1.3M | 370k | 3.52 | |
| Optinose (OPTN) | 0.5 | $1.3M | 65k | 20.00 | |
| Verastem | 0.5 | $1.2M | 400k | 2.98 | |
| Tesaro | 0.5 | $1.2M | 21k | 57.14 | |
| Enteromedics | 0.5 | $1.1M | 788k | 1.45 | |
| Spring Bk Pharmaceuticals In | 0.4 | $1.1M | 73k | 14.95 | |
| Gw Pharmaceuticals Plc ads | 0.4 | $1.1M | 9.6k | 112.71 | |
| Sangamo Biosciences (SGMO) | 0.4 | $1.0M | 53k | 18.94 | |
| Horizon Pharma | 0.4 | $979k | 69k | 14.19 | |
| ACADIA Pharmaceuticals (ACAD) | 0.4 | $961k | 43k | 22.47 | |
| Supernus Pharmaceuticals (SUPN) | 0.4 | $959k | 21k | 45.77 | |
| Anaptysbio Inc Common (ANAB) | 0.3 | $885k | 8.5k | 104.12 | |
| Amicus Therapeutics (FOLD) | 0.3 | $881k | 59k | 15.03 | |
| Portola Pharmaceuticals | 0.3 | $784k | 24k | 32.67 | |
| Aerie Pharmaceuticals | 0.3 | $802k | 15k | 54.27 | |
| Spark Therapeutics | 0.3 | $799k | 12k | 66.58 | |
| Esperion Therapeutics (ESPR) | 0.3 | $723k | 10k | 72.30 | |
| Radius Health | 0.3 | $675k | 19k | 35.91 | |
| Foamix Pharmaceuticals | 0.1 | $324k | 63k | 5.13 | |
| Viking Therapeutics (VKTX) | 0.1 | $305k | 70k | 4.36 |
